Lisu Wang

7.0k total citations · 2 hit papers
27 papers, 2.1k citations indexed

About

Lisu Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lisu Wang has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Lisu Wang's work include Phytochemistry and Biological Activities (6 papers), Natural product bioactivities and synthesis (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Lisu Wang is often cited by papers focused on Phytochemistry and Biological Activities (6 papers), Natural product bioactivities and synthesis (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Lisu Wang collaborates with scholars based in Taiwan, United States and China. Lisu Wang's co-authors include Ming‐Jiuan Wu, Jui-Hung Yen, Tzi-Wei Lian, Ching‐Yi Weng, Scott D. Chasalow, Vafa Shahabi, Rui‐Ru Ji, Maria Jure–Kunkel, David M. Berman and John Cogswell and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Agricultural and Food Chemistry.

In The Last Decade

Lisu Wang

27 papers receiving 2.0k citations

Hit Papers

An immune-active tumor microenvironment favors clinical r... 2011 2026 2016 2021 2011 2023 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisu Wang Taiwan 18 690 600 528 247 205 27 2.1k
Jie Jiang China 23 284 0.4× 449 0.7× 217 0.4× 140 0.6× 38 0.2× 90 1.6k
Rakesh Dixit India 28 636 0.9× 778 1.3× 220 0.4× 249 1.0× 129 0.6× 137 2.6k
Li Huang China 25 679 1.0× 861 1.4× 117 0.2× 146 0.6× 56 0.3× 72 2.4k
Manjinder Kaur United States 22 251 0.4× 825 1.4× 89 0.2× 144 0.6× 361 1.8× 42 1.7k
Chunyan Hu China 34 284 0.4× 1.2k 2.0× 212 0.4× 110 0.4× 40 0.2× 167 3.1k
Xiaoyu Tan China 23 111 0.2× 712 1.2× 230 0.4× 224 0.9× 62 0.3× 124 1.7k
Yujie Huang China 31 512 0.7× 1.8k 3.0× 392 0.7× 136 0.6× 77 0.4× 112 3.3k
Zhengyu Jiang China 32 373 0.5× 2.8k 4.6× 302 0.6× 294 1.2× 101 0.5× 122 3.8k
Amar Singh India 32 304 0.4× 1.2k 2.0× 202 0.4× 377 1.5× 85 0.4× 115 2.7k
Sang Joon Lee South Korea 25 308 0.4× 810 1.4× 106 0.2× 124 0.5× 53 0.3× 84 1.9k

Countries citing papers authored by Lisu Wang

Since Specialization
Citations

This map shows the geographic impact of Lisu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisu Wang more than expected).

Fields of papers citing papers by Lisu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisu Wang. The network helps show where Lisu Wang may publish in the future.

Co-authorship network of co-authors of Lisu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lisu Wang. A scholar is included among the top collaborators of Lisu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisu Wang. Lisu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abbas, Jawad, et al.. (2023). Investment in renewable energy and electricity output: Role of green finance, environmental tax, and geopolitical risk: Empirical evidence from China. Energy. 269. 126683–126683. 233 indexed citations breakdown →
2.
Wang, Lisu, et al.. (2022). Multiple penalized regularization for clusters with varying correlation levels. Statistics and Its Interface. 15(3). 373–382. 4 indexed citations
3.
Szabó, Péter M., Saumya Pant, Scott Ely, et al.. (2021). Development and Performance of a CD8 Gene Signature for Characterizing Inflammation in the Tumor Microenvironment across Multiple Tumor Types. Journal of Molecular Diagnostics. 23(9). 1159–1173. 7 indexed citations
4.
Qi, Zhenhao, Lisu Wang, Keyur Desai, et al.. (2019). Reliable Gene Expression Profiling from Small and Hematoxylin and Eosin–Stained Clinical Formalin-Fixed, Paraffin-Embedded Specimens Using the HTG EdgeSeq Platform. Journal of Molecular Diagnostics. 21(5). 796–807. 17 indexed citations
5.
Qi, Zhenhao, Lisu Wang, Aiqing He, Manling Ma-Edmonds, & John Cogswell. (2016). Evaluation and Selection of A Non-PCR Based Technology for Improved Gene Expression Profiling from Clinical Formalin-Fixed, Paraffin-Embedded Samples. Bioanalysis. 8(22). 2305–2316. 4 indexed citations
6.
Wang, Lisu, et al.. (2014). Anti-Inflammatory Effect and Mechanism of the Green Fruit Extract ofSolanum integrifoliumPoir.. BioMed Research International. 2014. 1–11. 10 indexed citations
8.
Shahabi, Vafa, David M. Berman, Scott D. Chasalow, et al.. (2013). Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events. Journal of Translational Medicine. 11(1). 75–75. 132 indexed citations
9.
Wang, Lisu, et al.. (2013). Arsenic trioxide induces unfolded protein response in vascular endothelial cells. Archives of Toxicology. 88(2). 213–226. 45 indexed citations
11.
Ji, Rui‐Ru, Scott D. Chasalow, Lisu Wang, et al.. (2011). An immune-active tumor microenvironment favors clinical response to ipilimumab. Cancer Immunology Immunotherapy. 61(7). 1019–1031. 593 indexed citations breakdown →
12.
Wang, Lisu, et al.. (2011). Lipoic acid ameliorates arsenic trioxide-induced HO-1 expression and oxidative stress in THP-1 monocytes and macrophages. Chemico-Biological Interactions. 190(2-3). 129–138. 25 indexed citations
13.
Yen, Jui-Hung, et al.. (2009). Regulation of heme oxygenase-1 expression and MAPK pathways in response to kaempferol and rhamnocitrin in PC12 cells. Toxicology and Applied Pharmacology. 237(1). 59–68. 76 indexed citations
14.
Lian, Tzi-Wei, et al.. (2008). Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1781(10). 601–609. 71 indexed citations
15.
Weng, Ching‐Yi, et al.. (2006). Immunomodulatory effect of Glossogyne tenuifolia in murine peritoneal macrophages and splenocytes. Journal of Ethnopharmacology. 107(1). 116–125. 39 indexed citations
16.
Wu, Ming‐Jiuan, Ching‐Yi Weng, Lisu Wang, & Tzi-Wei Lian. (2005). Immunomodulatory mechanism of the aqueous extract of sword brake fern (Pteris ensiformis Burm.). Journal of Ethnopharmacology. 98(1-2). 73–81. 24 indexed citations
17.
Wu, Ming‐Jiuan, et al.. (2005). Antioxidant Activity of Glossogyne tenuifolia. Journal of Agricultural and Food Chemistry. 53(16). 6305–6312. 47 indexed citations
18.
Wu, Ming‐Jiuan, Lisu Wang, Hsiou‐Yu Ding, Ching‐Yi Weng, & Jui-Hung Yen. (2004). <i>Glossogyne tenuifolia</i> Acts to Inhibit Inflammatory Mediator Production in a Macrophage Cell Line by Downregulating LPS-Induced NF-&kappa;B. Journal of Biomedical Science. 11(2). 186–199. 5 indexed citations
19.
Wu, Ming‐Jiuan, Lisu Wang, Hsiou‐Yu Ding, Ching‐Yi Weng, & Jui-Hung Yen. (2004). Glossogyne tenuifolia acts to inhibit inflammatory mediator production in a macrophage cell line by downregulating LPS-induced NF-κB. Journal of Biomedical Science. 11(2). 186–199. 58 indexed citations
20.
Wu, Ming‐Jiuan, Lisu Wang, Ching‐Yi Weng, & Jui-Hung Yen. (2003). Antioxidant Activity of Methanol Extract of the Lotus Leaf (Nelumbo nucifera Gertn.). The American Journal of Chinese Medicine. 31(5). 687–698. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026